COMMUNIQUÉS West-GlobeNewswire

Vital Therapies Announces VTL-308 Reaches Enrollment Target of 150 Subjects

22/03/2018 - 13:01

SAN DIEGO, March 22, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL ), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today [...]

Todos Medical reports on results of clinical trials for its blood test for breast cancer screening (TM - B1) conducted at Kaplan Hospital in Rehovot, Israel

22/03/2018 - 13:00

REHOVOT, Israel, March 22, 2018 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTC Pink:TOMDF) ( http://www.Todosmedical.com ) today announced the results of a clinical trial recently completed at Kaplan Hospital in Rehovot, [...]

Spero Therapeutics to Present at Upcoming Investor Conferences

22/03/2018 - 13:00

CAMBRIDGE, Mass., March 22, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO ), a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel [...]

Envigo to Expand Livermore, California Research Model Surgical Facility to Meet Rising Demand from West Coast Biopharmaceutical Companies

22/03/2018 - 13:00

East Millstone, N.J., March 22, 2018 (GLOBE NEWSWIRE) -- Envigo, a leading provider of nonclinical contract research services and research models, is investing in an expansion of its research model surgical facility at [...]

Progressive Care Releases Audited 2017 Annual Report

22/03/2018 - 13:00

MIAMI, March 22, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces 2017 annual results. The Company announced over $20 million in net revenues, a 10% [...]

Zealand Pharma convenes its Annual General Meeting 2018

22/03/2018 - 12:38

Company Announcement - No. 10/2018 Zealand Pharma convenes its Annual General Meeting 2018 Copenhagen, March 22, 2018 - Zealand Pharma A/S ("Zealand") convenes the Company's ordinary Annual General Meeting to be held on [...]

Precipio Restructures Capitalization Table

22/03/2018 - 12:37

NEW HAVEN, Conn., March 22, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO ), in an 8-K issued today announced an agreement with investors in certain 2017 underwritten and registered [...]

Avadel Pharmaceuticals Announces Promotion of Gregory J. Divis to Chief Operating Officer

22/03/2018 - 12:30

DUBLIN, Ireland, March 22, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ: AVDL ), “Avadel” or the “Company,” today announced the promotion of Gregory J. Divis to Executive Vice President and Chief [...]

Reata Announces Positive Top-Line Data for Treatment of PH-ILD With Bardoxolone Methyl From the Phase 2 Lariat Trial

22/03/2018 - 12:30

Significant Improvement in 6MWD in Patients With IPF and Sarcoidosis No Safety Signals Identified IRVING, Texas, March 22, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA ) (Reata or Company), a [...]

Helix BioPharma Corp Welcomes Drs. Daniel Von Hoff, Kazimierz Roszkowski-Sliz and Robert Gillies to Its Scientific and Strategic Advisory Board

22/03/2018 - 12:30

RICHMOND HILL, Ontario, March 22, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP ) (FSE:HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]

Young Doctors Warned of Pitfalls in Employment Contracts, in Journal of American Physicians and Surgeons (AAPS)

22/03/2018 - 15:01

TUCSON, Ariz., March 22, 2018 (GLOBE NEWSWIRE) -- Physicians just out of residency, experiencing their first taste of independence, need to beware of traps in employment contracts, writes Philip Eskew , D.O., J.D., M.B. [...]

Aino Health AB (publ): Aino Health AB signs contract with Multi Contact GmbH

22/03/2018 - 15:01

The German company Multi Contact, which is part of the Otto Group, has signed a contract with Aino Health regarding use of the IT platform HealthManager to improve Multi Contact's own health management. The deal also [...]

Notice to Convene Annual General Meeting 2018

22/03/2018 - 14:57

Company Announcement no. 05/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 22 March 2018 Notice to Convene Annual General Meeting 2018 The board of directors of Veloxis Pharmaceuticals A/S, CVR no. 26 52 77 67 (" [...]

CBT Pharmaceuticals to Grow Immuno-Oncology Pipeline by License Agreement of CrownBio CTLA-4 Antibody

22/03/2018 - 14:34

SAN DIEGO, March 22, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing [...]

CORRECTION: Recording of the Fourth Quarter 2017 Investor Conference Webinar (Presentation added)

22/03/2018 - 12:10

Olaine, 2018-03-22 12:10 CET (GLOBE NEWSWIRE) -- The recorded AS “Olainfarm” webinar is available online: http://ej.uz/OLF_Q4_2017 , and the presentation, demonstrated during the webinar, is available in the attachment [...]

Accelerate Diagnostics Inc. Announces $150 Million Convertible Notes Offering

22/03/2018 - 12:08

TUCSON, Ariz., March 22, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX ) today announced its intention to offer, subject to market conditions and other factors, $150.0 million aggregate principal [...]

Cocrystal Pharma Reports 2017 Financial Results and Provides Corporate Overview and Business Outlook

22/03/2018 - 12:05

–Company successfully completes uplisting to the NASDAQ Capital Market – –Company positioned to achieve clinical and regulatory milestones over the course of 2018– ATLANTA, GA and BOTHELL, WA, March 22, 2018 (GLOBE [...]

BioVie to Present at The MicroCap Conference in New York on April 9th

22/03/2018 - 12:00

BEVERLY, Mass., March 22, 2018 (GLOBE NEWSWIRE) -- BioVie Inc. (OTCQB:BIVI), a clinical-stage company focused on the development and commercialization of innovative drug therapies for liver disease, announced today that [...]

Zynerba Pharmaceuticals Announces Poster Presentation at the 2018 Annual Meeting of the American Academy of Neurology (AAN)

22/03/2018 - 11:45

DEVON, Pa., March 22, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE ), a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative [...]